Literature DB >> 29807203

Synergistic interactions of cryptotanshinone and aminoglycoside antibiotics against Staphylococcus aureus in vitro.

Zihao Teng1, Meng Li1, Dongxue Shi1, Xuming Deng2, Jianfeng Wang3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29807203     DOI: 10.1016/j.jgar.2018.05.013

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


× No keyword cloud information.
  5 in total

Review 1.  Effects of Traditional Chinese Medicine and its Active Ingredients on Drug-Resistant Bacteria.

Authors:  Jimin Li; Shanshan Feng; Xin Liu; Xu Jia; Fengling Qiao; Jinlin Guo; Shanshan Deng
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus.

Authors:  Zijing Ruan; Jiaqi Cui; Zhenqing He; Yuting Guo; Xu Jia; Xinhe Huang
Journal:  Infect Drug Resist       Date:  2020-08-13       Impact factor: 4.003

3.  New Insights Into the Antibacterial Mechanism of Cryptotanshinone, a Representative Diterpenoid Quinone From Salvia miltiorrhiza Bunge.

Authors:  Bo-Chen Chen; Zhi-Shan Ding; Jian-Sheng Dai; Ni-Pi Chen; Xing-Wen Gong; Lie-Feng Ma; Chao-Dong Qian
Journal:  Front Microbiol       Date:  2021-02-25       Impact factor: 5.640

4.  Identification of the antibacterial mechanism of cryptotanshinone on methicillin-resistant Staphylococcus aureus using bioinformatics analysis.

Authors:  Jiwei Zhong; Haidan Wang; Yun Zhuang; Qun Shen
Journal:  Sci Rep       Date:  2021-11-05       Impact factor: 4.379

5.  Cryptotanshinone Attenuates Airway Remodeling by Inhibiting Crosstalk Between Tumor Necrosis Factor-Like Weak Inducer of Apoptosis and Transforming Growth Factor Beta 1 Signaling Pathways in Asthma.

Authors:  Chongyang Wang; Mingyu Zheng; Yunho Choi; Jingzhi Jiang; Li Li; Junfeng Li; Chang Xu; Zhemin Xian; Yan Li; Hongmei Piao; Liangchang Li; Guanghai Yan
Journal:  Front Pharmacol       Date:  2019-11-11       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.